News

NEW FUNDING

The Lundbeck foundation donated 30.000 kr (~4 927 USD), to support the participation of the members of the Psychiatric Research Academy in the 26th European Psychiatric Association Congress in Nice, 2018.

Advertisements

AWARD

Christopher Rohde won the Best eposter award and 300 euro at the 26th European Congress of Psychiatry in Nice for his poster: Real-world Effectiveness of Clozapine for Mental Retardation: Results from a Mirror-image and a Reverse-mirror-image Study.

Congratulations!

WE WILL JOIN THE 19TH CONGRESS OF THE SECTION OF EPIDEMIOLOGI AND SOCIAL PSYCHIATRY OF THE EUROPEAN PSYCHIATRIC ASSOCIATION (EPA) IN VIENNA, AUSTRIA, APRIL 4-7, 2018.

Presenters at the conference:

  • Christina Elise Holm-Larsen: Influence of postpartum depression on child growth in a low-income setting (Oral presentation)
  • Christina Blanner Kristiansen: 1) Urban Mental Health – challenges and perspectives (poster) 2) Chairman and organizer of symposia “Young Scientists Cup”.
  • Mikkel Højlund: 1) Utilization of antipsychotic drugs in Scandinavia from 2006 to 2016, (oral presentation) 2) Chairman and organizer of symposia “Young Scientists Cup”.
  • Frederikke Kjerulff Madsen: Intimate Partner Violence Among Pregnant Women And Exclusive Breastfeeding (oral presentation)
  • Peter Næsborg Schøler: Elderly with relief/reward drinking patterns: characteristics and treatment outcomes (oral presentation)
  • Julie Eg Frøkjær: Cognitive and Vegetative Symptoms in Children and Adolescents Measured by the Mood and Feelings Questionnaire (poster)
  • Adam Felix Kemp Predictors: Predictors for hospitalization of children and adolescents with eating disorders (poster)
  • Helena Sandgreen and Alexander Lind Koch-Pedersen: Measuring the Development of a Research Organization by the Means of Bibliometrics (poster)

WE WILL JOIN THE 26TH EUROPEAN CONGRESS OF PSYCHIATRY IN NICE, FRANCE, MARCH 3-6 2018

Presenters at the conference:

  • Jesper Nørgaard Kjær: Workforce migration in the Scandinavian countries – do trainees still want to leave from what is perceived by everyone else as the paradise? (e-Poster Walk)
  • Christopher Rohde: Real-world Effectiveness of Clozapine for Mental Retardation: Results from a Mirror-image and a Reverse-mirror-image Study (ePoster Walk)
  • Clara Reece Medici: Typical and atypical antipsychotics in acute mania: Comparison of effectiveness (ePoster)
  • Astrid Harpøth: A preclinical assessment of the antidepressant-like effect of Isoflurane (ePoster)
  • Amalie Bach Dybdal: Can doctors apply treatment strategies for patients with bodily distress syndrome (ePoster)

NEW PUBLICATION

Christopher Rohde investigated the effects of clozapine in borderline personality disorder. Clozapine was associated with a reduction in psychiatric admissions from 2.52 (95%-CI 2.31-2.78) to 2.00 (95%-CI 1.77-2.23) admissions and a reduction in psychiatric bed-days from 190.08 (95%-CI 176.84-203.33) to 65.95 (95%-CI 58.27-73.66) bed-days. Further, the number of patients with intentional self-harm or overdose decreased significantly from 189 to 114 individuals after clozapine initiation. Read more here.